Zim Corp ZIMCF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.01 / $0.35
- Market Cap
- $8.14
- Volume/Avg
- 1,700 / 1,417
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Zim Corp has sold its operations and is currently focused on biomedical research. The company focused all of its resources on developing intellectual property and advancing research and development in the areas of new synthetic drugs and immunotherapies. It generates geographic revenue from Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.zim.biz
Valuation
|
Metric
|
ZIMCF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
ZIMCF
Financial Strength
|
Metric
|
ZIMCF
|
|---|---|
Quick Ratio | 2.91 |
Current Ratio | 3.60 |
Interest Coverage | 250.01 |
Quick Ratio
ZIMCF
Profitability
|
Metric
|
ZIMCF
|
|---|---|
Return on Assets (Normalized) | 17.12% |
Return on Equity (Normalized) | 17.90% |
Return on Invested Capital (Normalized) | 17.65% |
Return on Assets
ZIMCF
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Rxv | $454.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Hpdnn | $90.3 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Tymllc | $89.7 Bil | |
SGEN
| Seagen Inc Ordinary Shares | Gwyrvf | $40.2 Bil | |
MRNA
| Moderna Inc | Krz | $30.5 Bil | |
ARGX
| argenx SE ADR | Szfkx | $27.0 Bil | |
BNTX
| BioNTech SE ADR | Gsrhf | $23.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Vqwmym | $21.7 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Xcjnkrh | $17.8 Bil | |
INCY
| Incyte Corp | Kptbyjd | $12.3 Bil |